The U.S. Food and Drug Administration (FDA) approved the Barostim Neo System for the improvement of symptoms in patients with advanced heart failure who are not suited for treatment with other...
Hypertension
This page includes news and new technology on hypertension. The condition is caused by abnormally high blood pressure that causes excess force and pressure of the blood against the artery walls. Long-term, this can cause damage the vessels and contributes to heart disease. Therapies include antihypertensive medications such as diuretics and renal denervation therapy.
-
-
Investigators unveiled late-breaking clinical data from a first-of-its-kind physician sponsored clinical trial at the 2019 EuroPCR Annual Meeting, May 20-23 in Paris, France. The data indicate...
-
December 11, 2018 — Mylan Pharmaceuticals is expanding its consumer-level voluntary nationwide recall to include all lots of...
-
Kim Allan Williams, Sr., M.D., chief of the Division of Cardiology and...
Image courtesy of the American Heart Association
News | Hypertension | August 20, 2019
August 20, 2019 — In a...
Similar to a pacemaker, the Barostim Neo System uses a pulse generator implanted below the collar bone with a lead that attaches to the carotid artery in the neck. It delivers electrical impulses to baroreceptors in the neck, which sense how blood is flowing through the carotid arteries and relays information to the brain. The brain, in turn, sends signals to the heart and blood vessels that relax the blood vessels and inhibit the production of stress-related hormones to reduce heart failure symptoms.
Technology | Heart Failure | August 19, 2019
August 19, 2019 — The U.S. Food and Drug Administration (FDA) granted market clearance the Barostim Neo...
Screen grab of facial scan from the app. Image courtesy of Kang Lee.
News | Blood Pressure Monitor | August 06, 2019
August 6, 2019 — Blood...
News | Cardiovascular Clinical Studies | July 03, 2019
July 3, 2019 — The American College of Cardiology (ACC) has partnered with Veradigm, an Allscripts business unit, to...
News | Pharmaceuticals | June 14, 2019
June 14, 2019 — Quantum Genomics announced the enrollment of the first patient in its QUORUM Phase IIb study of its...
News | Hypertension | June 04, 2019
June 4, 2019 — Orchestra BioMed Inc. announced the presentation of two-year clinical data from the European Moderato...
News | Congenital Heart | June 03, 2019
June 3, 2019 — Researchers at University of California San Diego School of Medicine found...
News | Renal Denervation | May 23, 2019
May 23, 2019 – Investigators unveiled late-breaking clinical data from a first-of-its-kind physician sponsored...
William T. Abraham, M.D., in an interview with DAIC Editor Dave Fornell at TCT 2016.
News | Heart Failure | March 12, 2019
March 12, 2019 — V-Wave Ltd. announced that renowned heart failure cardiologist...
